Melatonin Treatment of Chronic Sleep Disorders

1998 ◽  
Vol 13 (2) ◽  
pp. 98-98 ◽  
Author(s):  
James E. Jan ◽  
Hilary Espezel ◽  
Roger D. Freeman ◽  
Diane K. Fast
2020 ◽  
Vol 10 (4) ◽  
pp. 219
Author(s):  
Beata Rzepka-Migut ◽  
Justyna Paprocka

Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are neurodevelopmental disorders with disturbed melatonin secretion profile and sleep problems. The growing incidence of ASD and ADHD inspires scientists to research the underlying causes of these conditions. The authors focused on two fundamental aspects, the first one being the presentation of the role of melatonin in ASD and ADHD and the second of the influence of melatonin treatment on sleep disorders. The authors present the use of melatonin both in the context of causal and symptomatic treatment and discuss melatonin supplementation: Dosage patterns, effectiveness, and safety. Sleep disorders may have a different clinical picture, so the assessment of exogenous melatonin efficacy should also refer to a specific group of symptoms. The review draws attention to the wide range of doses of melatonin used in supplementation and the need to introduce unified standards especially in the group of pediatric patients.


CNS Spectrums ◽  
2001 ◽  
Vol 6 (6) ◽  
pp. 502-506 ◽  
Author(s):  
Iris Haimov

AbstractBiological aging is often associated with sleep problems and daytime napping. Complaints of difficulty in initiating and maintaining sleep, as well as daytime drowsiness, are more common in the elderly than in any other age group. This report reviews evidence that impaired melatonin secretion is associated with sleep disorders in old age. Circulating melatonin levels have been found to be significantly lower and onset and peak times have been delayed in elderly insomniacs as compared to age-matched control subjects. In view of these findings, we investigated the effects of melatonin treatment on melatonin-deficient insomnia in the elderly. From the results of our study, it seems likely that melatonin replacement therapy may be beneficial in the initiation and maintenance of sleep in this population.


2009 ◽  
Vol 47 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Michel Hoebert ◽  
Kristiaan B. van der Heijden ◽  
Ingeborg M. van Geijlswijk ◽  
Marcel G. Smits

2000 ◽  
Vol 54 (3) ◽  
pp. 381-382 ◽  
Author(s):  
Yuichi Kamei ◽  
Tatsuro Hayakawa ◽  
Jujiro Urata ◽  
Makoto Uchiyama ◽  
Kayo Shibui ◽  
...  

2013 ◽  
Vol 11 (2) ◽  
pp. 99-104 ◽  
Author(s):  
Annette van Maanen ◽  
Julia F Dewald-Kaufmann ◽  
Marcel G Smits ◽  
Frans J Oort ◽  
Anne Marie Meijer

2014 ◽  
Vol 8 (6) ◽  
pp. 383-385 ◽  
Author(s):  
Thomas L. Lenz

Getting adequate sleep is a healthy lifestyle activity that is important for the body to function optimally both physically and mentally. Unfortunately, 70 million Americans suffer from chronic sleep loss or sleep disorders. Secondary causes of sleep disorders are often overlooked and can occur from the consumption of social or medicinal drugs. Common social drugs that can disrupt sleep include alcohol, caffeine, and nicotine. Certain medications can also have side-effects that can induce sleep disruptions. This article briefly reviews common social drugs and prescription medications that can negatively impact sleep.


Sign in / Sign up

Export Citation Format

Share Document